Pharmaceutical applications of hot-melt extrusion: Part I

被引:549
作者
Crowley, Michael M.
Zhang, Feng
Repka, Michael A. [1 ]
Thumma, Sridhar
Upadhye, Sampada B.
Battu, Sunil Kumar
McGinity, James W.
Martin, Charles
机构
[1] Univ Mississippi, Sch Pharm, Dept Pharmaceut, University, MS 38677 USA
[2] Univ Texas, Coll Pharm, Div Pharmaceut, Austin, TX 78712 USA
[3] PharmaForm LLC, Austin, TX USA
[4] Amer Leistritz Extruder Corp, Somerville, NJ USA
关键词
melt extrusion; thermal processing; solid dispersion; solid molecular dispersion; extruder; bioavailability; sustained release; immediate release; drug delivery systems;
D O I
10.1080/03639040701498759
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Interest in hot-melt extrusion techniques for pharmaceutical applications is growing rapidly with well over 100 papers published in the pharmaceutical scientific literature in the last 12 years. Hot-melt extrusion (HME) has been a widely applied technique in the plastics industry and has been demonstrated recently to be a viable method to prepare several types of dosage forms and drug delivery systems. Hot-melt extruded dosage forms are complex mixtures of active medicaments, functional excipients, and processing aids. HME also offers several advantages over traditional pharmaceutical processing techniques including the absence of solvents, few processing steps, continuous operation, and the possibility of the formation of solid dispersions and improved bioavailability. This article, Part I, reviews the pharmaceutical applications of hot-melt extrusion, including equipment, principles of operation, and process technology. The raw materials processed using this technique are also detailed and the physicochemical properties of the resultant dosage forms are described. Part II of this review will focus on various applications of HME in drug delivery such as granules, pellets, immediate and modified release tablets, transmucosal and transdermal systems, and implants.
引用
收藏
页码:909 / 926
页数:18
相关论文
共 110 条
[1]  
Aharoni SM, 1998, POLYM ADVAN TECHNOL, V9, P169, DOI 10.1002/(SICI)1099-1581(199803)9:3<169::AID-PAT740>3.3.CO
[2]  
2-Q
[3]   Hot melt extrusion of acrylic films [J].
AitkenNichol, C ;
Zhang, F ;
McGinity, JW .
PHARMACEUTICAL RESEARCH, 1996, 13 (05) :804-808
[4]  
ARWIDSSON H, 1991, ACTA PHARM NORDICA, V3, P65
[5]   In vitro evaluation of poly(D,L-lactide-co-glycolide) polymer-based implants containing the alpha-melanocyte stimulating hormone analog, Melanotan-I [J].
Bhardwaj, R ;
Blanchard, J .
JOURNAL OF CONTROLLED RELEASE, 1997, 45 (01) :49-55
[6]   In vitro characterization and in vivo release profile of a poly(D,L-lactide-co-glycolide)-based implant delivery system for the α-MSH analog, melanotan-I [J].
Bhardwaj, R ;
Blanchard, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 170 (01) :109-117
[7]   Melt extrusion: from process to drug delivery technology [J].
Breitenbach, J .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2002, 54 (02) :107-117
[8]  
Breitenbach J., 2003, PHARM EXTRUSION TECH, V133
[9]  
BRITTAIN HG, 1995, PHYS CHARACTERIZATIO, V70
[10]   Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid [J].
Bruce, LD ;
Shah, NH ;
Malick, AW ;
Infeld, MH ;
McGinity, JW .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 59 (01) :85-97